Female Sexual Dysfunction

  • Manu Lakshmi
  • Shah Dupesh Khan


Female sexual dysfunction (FSD) represents an enigmatic yet complex set of disorders in this millennia, wherein significant changes have been implemented in defining, categorizing and managing these conditions. FSD is best viewed through a biopsychosocial modelled approach that integrates the ever-changing scenarios that can affect a woman’s health [1]. This includes a woman’s psychological issues, interpersonal factors, her current health status and other sociocultural factors. Women’s sexuality is highly complex and the association between various factors like society, family, relationship and health is strictly non-linear in nature [2]. A problem in any one of these areas can ultimately result in a sexual dysfunction. The aim of this chapter is to briefly overview the female sexual interest/arousal disorder and orgasmic disorder and also outline the management of the same. Female pain disorders now reclassified as the genito-pelvic pain disorder have been comprehensively reviewed separately in the textbook.


  1. 1.
    Althof S, Leiblum S, Chevret-Meason M, et al. Psychological and interpersonal dimensions of sexual function or dysfunction. J Sex Med. 2005;26:793–800.CrossRefGoogle Scholar
  2. 2.
    Rosen RC, Barsky JL. Normal sexual response in women. Obstet Gynecol Clin N Am. 2006;33:515–26.CrossRefGoogle Scholar
  3. 3.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington, VA: American Psychiatric Publishing; 2013.CrossRefGoogle Scholar
  4. 4.
    Sungur MZ, Gunduz A. A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges. J Sex Med. 2014;11(2):364–73.CrossRefGoogle Scholar
  5. 5.
    Clayton AH, Hamilton DV. Female sexual dysfunction. Obstet Gynecol Clin. 2009;36(4):861–76.CrossRefGoogle Scholar
  6. 6.
    Giles KR, McCabe MP. Conceptualizing women’s sexual function: linear vs. circular models of sexual response. J Sex Med. 2009;6(10):2761–71.CrossRefGoogle Scholar
  7. 7.
    Masters WH, Masters VJ. Human sexual inadequacy. New York City, New York: Bantam Books; 1980.Google Scholar
  8. 8.
    Sarin S, Amsel RM, Binik YM. Disentangling desire and arousal: a classificatory conundrum. Arch Sex Behav. 2013;42:1079–100.CrossRefGoogle Scholar
  9. 9.
    Graham CA, Brotto LA, Zucker KJ. Response to Balon and Clayton (2014): female sexual interest/arousal disorder is a diagnosis more on firm ground than thin air. Arch Sex Behav. 2014;43:1231–4.CrossRefGoogle Scholar
  10. 10.
    Balon R, Clayton AH. Female sexual interest/arousal disorder: a diagnosis out of thin air. Arch Sex Behav. 2014;43:1227–9.CrossRefGoogle Scholar
  11. 11.
    Bachmann GA, Leiblum S, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol. 1989;73(3 pt 1):425–7.PubMedGoogle Scholar
  12. 12.
    Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13(suppl 6):S1–4.CrossRefGoogle Scholar
  13. 13.
    Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med. 1997;19:387–91.CrossRefGoogle Scholar
  14. 14.
    Michael RT. Sex in America: a definitive survey. Boston: Little, Brown; 1994. p. 111–31.Google Scholar
  15. 15.
    Flynn KE, Reese JB, Jeffery DD, et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology. 2012;21:594–601.CrossRefGoogle Scholar
  16. 16.
    Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–8.CrossRefGoogle Scholar
  17. 17.
    Kontula O, Haavio-Mannila E. Sexual pleasures. Enhancement of sex life in Finland 1971–1992. Dartmouth (NH): Aldershot Publishing; 1995.Google Scholar
  18. 18.
    Rosen C, Brown J, Heiman S, Leiblum C, Meston R, Shabsigh D, Ferguson R, D'Agostino R. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.CrossRefGoogle Scholar
  19. 19.
    Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med. 2002;11(3):277–89.CrossRefGoogle Scholar
  20. 20.
    Flynn KE, Lin L, Cyranowski JM, et al. Development of the NIH PROMIS® sexual function and satisfaction measures in patients with cancer. J Sex Med. 2013;10:43–52.CrossRefGoogle Scholar
  21. 21.
    Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician. 2000;62(1):127–48.PubMedGoogle Scholar
  22. 22.
    Meston C, Buss D. Why women have sex: sexual motivation from adventure to revenge—and everything in between. London: The Bodley Head; 2009.Google Scholar
  23. 23.
    Clayton AH, Juarez EM. Female sexual dysfunction. Psychiatr Clin. 2017;40(2):267–84.Google Scholar
  24. 24.
    Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L. Female sexual dysfunction—medical and psychological treatments, committee 14. J Sex Med. 2017;14(12):1463–91.CrossRefGoogle Scholar
  25. 25.
    Graziottin A, Leiblum SR. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med. 2005;2(s3:133–45.CrossRefGoogle Scholar
  26. 26.
    Rowland DL, Kolba TN. Understanding orgasmic difficulty in women. J Sex Med. 2016;13(8):1246–54.CrossRefGoogle Scholar
  27. 27.
    Clark L. Is there a difference between a clitoral and a vaginal orgasm? J Sex Res. 1970;6(1):25–8.CrossRefGoogle Scholar
  28. 28.
    Barbach LG. Group treatment of preorgasmic women. J Sex Marital Ther. 1974;1:139–45.CrossRefGoogle Scholar
  29. 29.
    Wylie K, Levin R, Hallam-Jones R, et al. Sleep exacerbation of persistent sexual arousal syndrome in a postmenopausal woman. J Sex Med. 2006;3:296–302.CrossRefGoogle Scholar
  30. 30.
    Komisaruk BR, Whipple B, Crawford A, et al. Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res. 2004;1024:77–88.CrossRefGoogle Scholar
  31. 31.
    Bradford A. Inhibited sexual desire in women. In: Grossman L, Walfish R, editors. Translating psychological research into practice. New York: Springer; 2014. p. 515–8.Google Scholar
  32. 32.
    Nairne KD, Hemsley DR. The use of directed masturbation training in the treatment of primary anorgasmia. Br J Clin Psychol. 1983;22:283–94.CrossRefGoogle Scholar
  33. 33.
    Riley AJ, Riley EJ. A controlled study to evaluate directed masturbation in the management of primary orgasmic failure in women. Br J Psychiatry. 1978;133:404–9.CrossRefGoogle Scholar
  34. 34.
    American Psychiatric Association. Training in and dissemination of empirically-validated psychological treatments: report and recommendations. Clin Psychol. 1995;48:3–24.Google Scholar
  35. 35.
    Schick V, Herbenick D, Rosenberger JG, et al. Prevalence and characteristics of vibrator use among women who have sex with women. J Sex Med. 2011;8:3306–15.CrossRefGoogle Scholar
  36. 36.
    Melnik T, Hawton K, McGuire H. Interventions for vaginismus. Cochrane Database Syst Rev. 2012;12:CD001760.PubMedGoogle Scholar
  37. 37.
    Davis SR, Worsley R, Miller KK, et al. Androgens and female sexual function and dysfunction- findings from the fourth international consultation of sexual medicine. J Sex Med. 2016;13(2):168–78.CrossRefGoogle Scholar
  38. 38.
    Bachmann GA, Komi JO. Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause. 2010;17(3):480–6.PubMedGoogle Scholar
  39. 39.
    Gao Z, Yang D, Yu L, et al. Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis. J Sex Med. 2015;12:2095–104.CrossRefGoogle Scholar
  40. 40.
    Berman JR, Berman LA, Toler SM, et al. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind placebo controlled study. J Urol. 2003;170(6 Pt 1):2333–8.CrossRefGoogle Scholar
  41. 41.
    Basson R, McInnes R, Smith MD, et al. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11(4):367–77.CrossRefGoogle Scholar
  42. 42.
    Caruso S, Intelisano G, Lupo L, et al. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo controlled study. BJOG. 2001;108(6):623–8.PubMedGoogle Scholar
  43. 43.
    Ito TY, Polan ML, Whipple B, et al. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. J Sex Marital Ther. 2006;32(5):369–78.CrossRefGoogle Scholar
  44. 44.
    Magon N, Kalra S. The orgasmic history of oxytocin: love, lust and labor. Indian J Endocrinol Metab. 2011;15(Suppl 3):S156–61.CrossRefGoogle Scholar
  45. 45.
    Behnia B, Heinrichs M, Bergmann W, et al. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Horm Behav. 2014;65:308–18.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Manu Lakshmi
    • 1
  • Shah Dupesh Khan
    • 2
  1. 1.Department of Reproductive MedicineThe Metromale Clinic & Fertility CenterChennaiIndia
  2. 2.The Metromale Clinic and Fertility CenterChennaiIndia

Personalised recommendations